Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | INPPL1 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | FBRSL1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | LAT2 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
mRNA | METAP2 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
mRNA | EIF5A | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
mRNA | CD300LF | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | LSM14B | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | SLC50A1 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | PAK5 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | WAS | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-06 |